Thoracic incisions are the portals of choice for accessing thoracic organs. There are instances, however, that more than one incision are required at the same or a later stage, in order to access other, thoracic or extrathoracic, organs for more complicated procedures. Then again, a single thoracic incision may offer more than adequate access to extrathoracic organs and in selected cases becomes valuable surgical approach to organs of the upper abdomen or the contralateral hemithorax. The experience with this technique is discussed.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s13304-014-0271-2 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Introduction: Only a few studies analysed the prognosis significance of erythema nodosum (EN) in sarcoidosis. Our objective was to analyze the prevalence of EN in sarcoidosis, its possible association of EN with extrathoracic sarcoidosis, and its prognostic significance.
Methods: Retrospective study including patients diagnosed with sarcoidosis at Bellvitge University Hospital, Barcelona, Spain, between 1980 and 2017.
Exploring the Role of Preoperative Systemic Therapy and Primary Resection in NSCLC With Extrathoracic Metastases: Identifying the Optimal Candidates.
Cancer Control
December 2024
Department of Medical Oncology; Sir Run Run Shaw Hospital; School of Medicine, Zhejiang University, Hangzhou, PR China.
Article Synopsis
- * Results show that adding PRT significantly improves overall survival in patients treated with chemotherapy, though the benefit is less pronounced in the immunotherapy era and not observed in patients with multiple distant metastases.
- * A predictive nomogram was developed to help identify patients who would benefit most from PRT, indicating that those receiving systemic preoperative therapy had better outcomes.
Proposed Ninth Edition TNM Staging System for Lung Cancer: Guide for Radiologists.
Radiographics
December 2024
From the Division of Diagnostic Imaging, The Chaim Sheba Medical Center, Tel Hashomer, 2 Derech Sheba St, Ramat Gan 5265601, Israel (M.K., Z.K., V.S., E.M.M.); Tel Aviv University Faculty of Medicine, Tel Aviv, Israel (M.K., Z.K., V.S., E.O., E.M.M.); Division of Cardiothoracic Imaging, University of Pittsburgh Medical Center, Pittsburgh, Pa (Z.K.); Department of Thoracic Imaging, University of Texas MD Anderson Cancer Center, Houston, Tex (M.T.T., R.A.); and Institute of Pathology, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel (E.O.).
Lung cancer continues to be the primary cause of cancer-related deaths globally. Precise staging is imperative for the development of successful treatment approaches and improvement of patient outcomes. Traditionally, lung cancer staging has depended on the TNM staging system, and the International Association for the Study of Lung Cancer (IASLC) has recently recommended modifications.
View Article and Find Full Text PDFEstimation and analysis ofvalues forI using paediatric mesh type reference computational phantoms.
J Radiol Prot
November 2024
Internal Dosimetry Section, Radiation Safety Systems Division, Bhabha Atomic Research Centre, Mumbai 400085, India.
This study examines the effect of paediatric mesh-type reference computational phantoms on organvalues resulting from radioiodine (I) intake. Using Geant4, we estimatedIvalues for 30 radiosensitive target tissues due to emission from the thyroid (Target ← Thyroid) in these phantoms. Our results show thatvalues differ between male and female phantoms of the same age andvalues also decrease as phantom age increases.
View Article and Find Full Text PDFThe prognosis and metabolite changes of NSCLC patients receiving first-line immunotherapy combined chemotherapy in different M1c categories according to 9th edition of TNM classification.
Cancer Med
September 2024
Department of Respiratory and Critical Care Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Article Synopsis
- The TNM Classification for lung cancer's 9th edition divides M1c into M1c1 (multiple lesions in one organ system) and M1c2 (multiple lesions across different organ systems), with M1c1 patients showing better overall survival than M1c2.
- The study involved 33 M1c1 and 22 M1c2 NSCLC patients without driver mutations, all receiving first-line immune checkpoint inhibitors and chemotherapy, analyzing the impact of metastatic patterns on progression-free survival (PFS) and conducting metabolomics analysis on their serum samples.
- Results indicated that there's a significant relationship between metastatic patterns and patient outcomes, with ongoing research needed to identify specific metabolites that may help predict treatment success for these patients.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!